Page last updated: 2024-09-03

dx 9065a and fondaparinux

dx 9065a has been researched along with fondaparinux in 5 studies

Compound Research Comparison

Studies (dx 9065a)	Trials (dx 9065a)	Recent Studies (post-2010) (dx 9065a)	Studies (fondaparinux)	Trials (fondaparinux)	Recent Studies (post-2010) (fondaparinux)
92	7	8	1,190	112	559

Protein Interaction Comparison

Protein	Taxonomy	dx 9065a (IC50)	fondaparinux (IC50)
Coagulation factor X	Homo sapiens (human)		0.011

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexander, JH; Singh, KP	1
Haas, S; Kubitza, D	1
Graff, J; Harder, S; Picard-Willems, B	1
Arora, R; Chandrasekar, S; Loomba, R; Shah, P	1
Ono, T	1

Reviews

4 review(s) available for dx 9065a and fondaparinux

Article	Year
Inhibition of Factor Xa : a potential target for the development of new anticoagulants. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2005, Volume: 5, Issue:5 Topics: Amino Acid Sequence; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithrombin III; Blood Coagulation; Drug Design; Fondaparinux; Humans; Molecular Sequence Data; Naphthalenes; Polysaccharides; Propionates; Venous Thrombosis	2005
Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:8 Topics: Administration, Oral; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Humans; Injections, Intravenous; Injections, Subcutaneous; Morpholines; Naphthalenes; Oligosaccharides; Polysaccharides; Propionates; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thromboembolism	2006
The need for novel anticoagulation therapy in acute coronary syndrome. American journal of therapeutics, 2013, Volume: 20, Issue:1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Cyclic N-Oxides; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Morpholines; Naphthalenes; Polysaccharides; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Treatment Outcome; Warfarin	2013
[Roles of coagulation pathway and factor Xa in chronic kidney disease (CKD)]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:4 Topics: Animals; Blood Coagulation; Disease Models, Animal; Extracellular Matrix; Factor V; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Humans; Mice; Molecular Targeted Therapy; Naphthalenes; Polysaccharides; Propionates; Proteinuria; Rats; Receptor, PAR-2; Renal Insufficiency, Chronic; Signal Transduction	2012

Other Studies

1 other study(ies) available for dx 9065a and fondaparinux

Article	Year
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a. International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:4 Topics: Adult; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Daboia; Drug Monitoring; Enoxaparin; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Naphthalenes; Partial Thromboplastin Time; Polysaccharides; Propionates; Thromboplastin; Viper Venoms	2007

Article

Year

Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a.

International journal of clinical pharmacology and therapeutics, 2007, Volume: 45, Issue:4

Topics: Adult; Animals; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Daboia; Drug Monitoring; Enoxaparin; Factor Xa Inhibitors; Fondaparinux; Heparin; Humans; Naphthalenes; Partial Thromboplastin Time; Polysaccharides; Propionates; Thromboplastin; Viper Venoms

2007